Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Suzuki

Showing results (21-30 of 354) with videos related to

Pageof 36
Sort By:
BMC Research Notes|May 10, 2022
Mouse mesoderm-specific transcript inhibits adipogenic differentiation and induces trans-differentiation into hepatocyte-like cells in 3T3-L1 preadiocytesYoshito Kadota, Takashige Kawakami, Masao Sato, et al.
American Heart Journal|March 6, 2020
Impact of creatinine clearance on clinical outcomes in elderly atrial fibrillation patients receiving apixaban: J-ELD AF Registry subanalysisMasaharu Akao, Takeshi Yamashita, Shinya Suzuki, et al.
European Journal of Clinical Pharmacology|May 27, 2020
Clinical implications of assessment of apixaban levels in elderly atrial fibrillation patients: J-ELD AF registry sub-cohort analysisShinya Suzuki, Takeshi Yamashita, Masaharu Akao, et al.
Materials (Basel, Switzerland)|August 10, 2017
Silicate Removal in Aluminum Hydroxide Co-Precipitation ProcessChiharu Tokoro, Shinya Suzuki, Daisuke Haraguchi, et al.
Microsurgery|January 6, 2026
Microsurgery Training Model Simulating Respiratory MotionRiku Katayama, Jun Araki, Shinya Suzuki, et al.
Clinical Cardiology|November 19, 2019
A multicenter prospective cohort study to investigate the effectiveness and safety of apixaban in Japanese elderly atrial fibrillation patients (J-ELD AF Registry)Ken Okumura, Takeshi Yamashita, Shinya Suzuki, et al.
Expert Opinion on Drug Safety|February 18, 2021
Long-term safety and efficacy of agalsidase beta in Japanese patients with Fabry disease: aggregate data from two post-authorization safety studiesMina Tsurumi, Shinya Suzuki, Jiro Hokugo, et al.
European Journal of Clinical Pharmacology|May 20, 2021
Predictors for a high apixaban level in elderly patients with atrial fibrillation prescribed reduced dose of apixabanShinya Suzuki, Takeshi Yamashita, Masaharu Akao, et al.
The Annals of Pharmacotherapy|July 27, 2019
Evaluation of Acute Kidney Injury Associated With Anticancer Drugs Used in Gastric Cancer in the Japanese Adverse Drug Event Report DatabaseMayako Uchida, Yuki Kondo, Shinya Suzuki, et al.
Zootaxa|October 21, 2025
A new species and a new record of the genus Eupoecilia Stephens, 1829 (Lepidoptera, Tortricidae, Tortricinae) in JapanShinya Suzuki, Utsugi Jinbo, Sadahisa Yagi, et al.
Pageof 36

Showing results (21-30 of 354) with videos related to

Sort By:
Pageof 36
BMC Research Notes|May 10, 2022
Mouse mesoderm-specific transcript inhibits adipogenic differentiation and induces trans-differentiation into hepatocyte-like cells in 3T3-L1 preadiocytesYoshito Kadota, Takashige Kawakami, Masao Sato, et al.
American Heart Journal|March 6, 2020
Impact of creatinine clearance on clinical outcomes in elderly atrial fibrillation patients receiving apixaban: J-ELD AF Registry subanalysisMasaharu Akao, Takeshi Yamashita, Shinya Suzuki, et al.
European Journal of Clinical Pharmacology|May 27, 2020
Clinical implications of assessment of apixaban levels in elderly atrial fibrillation patients: J-ELD AF registry sub-cohort analysisShinya Suzuki, Takeshi Yamashita, Masaharu Akao, et al.
Materials (Basel, Switzerland)|August 10, 2017
Silicate Removal in Aluminum Hydroxide Co-Precipitation ProcessChiharu Tokoro, Shinya Suzuki, Daisuke Haraguchi, et al.
Microsurgery|January 6, 2026
Microsurgery Training Model Simulating Respiratory MotionRiku Katayama, Jun Araki, Shinya Suzuki, et al.
Clinical Cardiology|November 19, 2019
A multicenter prospective cohort study to investigate the effectiveness and safety of apixaban in Japanese elderly atrial fibrillation patients (J-ELD AF Registry)Ken Okumura, Takeshi Yamashita, Shinya Suzuki, et al.
Expert Opinion on Drug Safety|February 18, 2021
Long-term safety and efficacy of agalsidase beta in Japanese patients with Fabry disease: aggregate data from two post-authorization safety studiesMina Tsurumi, Shinya Suzuki, Jiro Hokugo, et al.
European Journal of Clinical Pharmacology|May 20, 2021
Predictors for a high apixaban level in elderly patients with atrial fibrillation prescribed reduced dose of apixabanShinya Suzuki, Takeshi Yamashita, Masaharu Akao, et al.
The Annals of Pharmacotherapy|July 27, 2019
Evaluation of Acute Kidney Injury Associated With Anticancer Drugs Used in Gastric Cancer in the Japanese Adverse Drug Event Report DatabaseMayako Uchida, Yuki Kondo, Shinya Suzuki, et al.
Zootaxa|October 21, 2025
A new species and a new record of the genus Eupoecilia Stephens, 1829 (Lepidoptera, Tortricidae, Tortricinae) in JapanShinya Suzuki, Utsugi Jinbo, Sadahisa Yagi, et al.
Pageof 36